Medications

Impavido approved to treat tropical parasitic disease

(HealthDay)—Impavido (miltefosine) has been approved by the U.S. Food and Drug Administration to treat adults with leishmaniasis, a tropical disease caused by a parasite that's transmitted by the bites of sand flies.

Diseases, Conditions, Syndromes

Kala-azar treatment failing in Nepal

In a recent study, scientists have concluded that the cure rates of Miltefosine, the only oral drug for visceral leishmaniasis available, have significantly decreased. Miltefosine was introduced in the Indian subcontinent ...

Diseases, Conditions, Syndromes

Sandfly spit vaccinates mice against leishmaniasis infection

A vaccine against cutaneous leishmaniasis, a skin infection caused by Leishmania parasites, may be spitting distance away—sand fly spit, that is. Saliva from a species of the fly responsible for transmitting leishmaniasis ...

Diseases, Conditions, Syndromes

Human neutrophil peptide-1: A new anti-leishmanial drug candidate

Leishmaniasis is a vector borne disease caused by different Leishmania species with different clinical manifestations. Cutaneous leishmaniasis (CL) is endemic and widespread especially among young individuals in Iran. Currently ...

page 5 from 8